Cargando…
Modulation of intracellular kinase signaling to improve TIL stemness and function for adoptive cell therapy
INTRODUCTION: Adoptive cellular therapy with tumor‐infiltrating lymphocytes (TIL) has demonstrated promising clinical benefits in several solid tumors, but the efficacy of this therapy might be compromised by the “prone‐to‐exhaustion” phenotype of TIL and poor persistence in vivo. This calls for a r...
Autores principales: | Feng, Hao, Qiu, Ling, Shi, Zixiao, Sheng, Yao, Zhao, Peipei, Zhou, Di, Li, Fei, Yu, Hailin, You, Yanan, Wang, Hui, Li, Ming, Zhu, Shurong, Du, Yan, Cui, Jun, Sun, Jingwei, Liu, Yarong, Jiang, Hua, Wu, Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939193/ https://www.ncbi.nlm.nih.gov/pubmed/36028997 http://dx.doi.org/10.1002/cam4.5095 |
Ejemplares similares
-
Adoptive TIL in HPV-negative oral scca
por: Leidner, Rom, et al.
Publicado: (2015) -
Adoptive TIL Transfer in the Adjuvant Setting for Melanoma: Long-Term Patient Survival
por: Khammari, Amir, et al.
Publicado: (2014) -
Evaluating different adoption scenarios for TIL-therapy and the influence on its (early) cost-effectiveness
por: Lindenberg, Melanie, et al.
Publicado: (2020) -
Adoptive transfer of TILs plus anti-PD1 therapy: An alternative combination therapy for treating metastatic osteosarcoma
por: Wang, Chao, et al.
Publicado: (2020) -
Fysikkpris til Fanamann
Publicado: (1981)